Forecast & Rating2 analysts currently cover Biofrontera, of which 2 give a positive rating. The average price target is $6.00, about 297.4% upside from the current price of $1.51. Coverage is limited, so the data is for reference only. Data as of Aug 19, 2026; this does not constitute investment advice.
Aug 14, 2026Price forecast
$6.00297.35%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met0.0%
Stock price$1.51
Avg. target$6.0
High target$9
Low target$3
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.